Skip to main content

Peripheral Nervous System

9
Publications
88.89
%Q1
20
Number of citations
40.00
% Open Access Publications
4
Ongoing Projects
0
Number of Presented Theses
25
Number of Active Clinical Trials
The laboratory’s two main lines of research have been, on the one hand, the development of biological biomarkers that serve as diagnostic, prognostic, and treatment-response tools in various neuromuscular diseases, particularly amyotrophic lateral sclerosis, immune-mediated neuropathies, and myasthenia gravis; and, on the other hand, the performance of high-resolution genetic studies (RNAseq, whole exome sequencing) for the diagnosis of myopathies not identified with standard techniques. In addition, we have participated in 15 clinical trials in myasthenia gravis, ALS, and immune-mediated neuropathies.

eCORE

  • Woman & Child Health & Rare Diseases

Team

Group Leader
Raul Juntas Morales

Principal Investigator (PI)
Raul Juntas Morales

Researchers
Jose Manuel Vidal Taboada, David Ovelleiro Fraile, Sara Marmolejo Martinez Artesero, Silvia Sanchez Martin

PhD Students
Daniel Sanchez Tejerina San Jose, Jose Alemany Diez, Arnau Llaurado Gayete, Juan Luis Restrepo Vera

Lab Technicians
Paula Sanche Alvarez

Nursing and Technical Staff
Viviana Jaumandreu, Helena Saez Fresno, Cinta Soler Angrill, David Funes Sanchez, Anna Canovas Segura, Conseulo Garcia Carmona, Mireia Santos Montes

Selected Publications

Selected Projects

Desarrollo e implementación de un nuevo panel de biomarcadores clínicos y moleculares para pronosticar la progresión y la supervivencia en pacientes con ELA
Principal Investigator: RAUL JUNTAS MORALES
Agency: Proyecto PI23/00850, financiado por Instituto de Salud Carlos III
Funding: 190,000 €
Period: 2024-2026

Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients
Principal Investigator: RAUL JUNTAS MORALES
Agency: Proyecto FCO.LUZON/PROJECTES/2024/JUNT AS, financiado por Fundación Francisco Luzón
Funding: 160,000 €
Period: 2024-2027

Desarrollo de un panel de biomarcadores (clínicos, moleculares, electrofisiológicos y de neuroimagen) como herramienta clínica de apoyo al diagnóstico, pronóstico y estratificación de los pacientes con Esclerosis Lateral Amiotrófica
Principal Investigator: RAUL JUNTAS MORALES
Agency: FUNDELA
Funding: 35,000 €
Period: 2024-2026

VHIR Annual Report 2024